ArrowMark Colorado Holdings’s Pfizer PFE Stock Holding History

ArrowMark Colorado Holdings’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-524,252	Closed	-$15.6M	–	280
2015 Q3	$15.6M	Hold	524,252	–	–	0.43%	68
2015 Q2	$16.7M	Buy	524,252 +145,197	+38%	+$4.73M	0.41%	71
2015 Q1	$12.5M	Buy	379,055 +20,881	+6%	+$664K	0.32%	96
2014 Q4	$10.6M	Buy	+358,174	New	+$10.3M	0.27%	107
2014 Q1	–	Sell	-369	Closed	-$11K	–	332
2013 Q4	$11K	Buy	+369	New	+$10.7K	﹤0.01%	315

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ArrowMark Colorado Holdings's PFE Position: Q4 2015 in Review

ArrowMark Colorado Holdings sold out of Pfizer (PFE) in Q4 2015, closing a stake of 524,252 shares — an estimated $15.6M sold.

ArrowMark Colorado Holdings first reported a position in PFE in Q4 2013 and held it in 5 quarters. The position peaked at $16.7M in Q2 2015. 1,969 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

ArrowMark Colorado Holdings reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
ArrowMark Colorado Holdings sold 524,252 Pfizer shares in Q4 2015, an estimated $15.6M.
ArrowMark Colorado Holdings first reported a position in Pfizer in Q4 2013 and held it in 5 quarters.
ArrowMark Colorado Holdings's Pfizer position peaked at $16.7M in Q2 2015.
1,969 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2015, filed 16 Feb 2016.